Abstract
The prevalence of metabolic syndrome is increasing worldwide and exhibits variation among ethnic groups. The objective of this study was to estimate and compare the prevalence of metabolic syndrome and its components between two ethnic groups (Circassians and Chechens) in Jordan and the original inhabitants of Jordan. Data were collected from a cross-sectional study of Circassian (n = 436), Chechen (n = 355), and Jordanian (n = 3234) population aged 18 years and older. Metabolic syndrome was defined according to International Diabetes Federation criteria. Age-standardized prevalence rate of metabolic syndrome was Jordanians 38.0 %, Circassians 32.0 %, and Chechens 33.7 %. Compared to Jordanians, both minority groups had lower means of body mass index, total cholesterol, fasting blood glucose, and triglycerides. The means of high-density lipoprotein and low-density lipoprotein were significantly higher among Circassians compared to Jordanians and Chechens. The odds of BMI defined by overweight and obesity and diabetes were less common among Circassians and Chechens compared to Jordanians. The prevalence of the metabolic syndrome and its individual components is relatively high in the three ethnic groups compared to world. Variation in components between groups may relate to ethnicity. Therefore, a community-based integrated approach is needed that would include behavioral, social changes that would lead to the prevention and treatment of the metabolic syndrome.
Similar content being viewed by others
Abbreviations
- CVD:
-
Cardiovascular disease
- DBP:
-
Diastolic blood pressure
- LDL:
-
Low-density lipoprotein
- HDL:
-
High-density lipoprotein
- MeS:
-
Metobolic syndrome
- SBP:
-
Systolic blood pressure
References
WHO, W.H.O.: Core Health Indicators. World Health Statistics In. (2006)
Ministry of Health, T.H.K.o.J., Mortality in Jordan (Ministry of Health, The Hashemite Kingdom of Jordan, Amman, 2008)
K. Ajlouni, Y.S. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, An increase in prevalence of diabetes mellitus in Jordan over 10 years. J. Diabetes Complicat. 22(5), 317–324 (2008)
Y. Khader, A. Batieha, H. Ajlouni, M. El-Khateeb, K. Ajlouni, Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab. Syndr. Relat. Disord. 6(2), 113–120 (2008)
F.M. Mubarak, E.S. Froelicher, H.Y. Jaddou, K.M. Ajlouni, Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann. Saudi Med. 28(5), 346–351 (2008)
Y.S. Khader, A. Batieha, M. El-Khateeb, M. Al Omari, K. Ajlouni, Prevalence of dyslipidemia and its associated factors among Jordanian adults. J. Clin. Lipidol. 4(1), 53–58 (2010)
Y. Khader, A. Bateiha, M. El-Khateeb, A. Al-Shaikh, K. Ajlouni, High prevalence of the metabolic syndrome among Northern Jordanians. J. Diabetes Complicat. 21(4), 214–219 (2007)
K. Shishani, R. Dajani, Y. Khader, Hypertension risk assessment in the largest ethnic groups in Jordan. J. Immigrant Minority Health (2011). doi:10.1007/s10903-011-9533-y
G. Barbujani, I.S. Nasidze, G.N. Whitehead, Genetic diversity in the Caucasus. Hum. Biol. 66(4), 639–668 (1994)
W. Richmond, The Northwest Caucasus: Past, Present, Future, vol. 12. Central Asian Studies Series Routledge (Routledge Press, Routledge, 2008)
K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640–1645 (2009)
Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163(4), 427–436 (2003)
L.A. Jaber, M.B. Brown, A. Hammad, Q. Zhu, W.H. Herman, The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 27(1), 234–238 (2004)
H.F. Abdul-Rahim, A. Husseini, E. Bjertness, R. Giacaman, N.H. Gordon, J. Jervell, The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 24(2), 275–279 (2001)
J.A. Al-Lawati, A.J. Mohammed, H.Q. Al-Hinai, P. Jousilahti, Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26(6), 1781–1785 (2003)
A.K. Ozsahin, A. Gokcel, N. Sezgin, M. Akbaba, N. Guvener, L. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17(4), 230–234 (2004)
F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract. 61(1), 29–37 (2003)
A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60(3), 199–204 (2003)
D.B. Carr, K.M. Utzschneider, R.L. Hull, K. Kodama, B.M. Retzlaff, J.D. Brunzell, J.B. Shofer, B.E. Fish, R.H. Knopp, S.E. Kahn, Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53(8), 2087–2094 (2004)
C.H. Tsai, T.C. Li, C.C. Lin, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40(2), 256–264 (2011)
A. Esteghamati, A. Zandieh, O. Khalilzadeh, A. Morteza, A. Meysamie, M. Nakhjavani, M.M. Gouya, Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine 38(2), 206–213 (2010)
S. Taslim, E.S. Tai, The relevance of the metabolic syndrome. Ann. Acad. Med. Singapore 38(1), 29–30 (2009)
H.N. Ginsberg, P.R. MacCallum, The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J. Cardiometab. Syndr. 4(2), 113–119 (2009)
Acknowledgments
This study has been funded by the Higher Council of Science and Technology, Jordan. We would like to thank the Circassian and Chechan communities for their participation in this study.
Conflict of interest
The authors declare that there are no competing financial interests associated with this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dajani, R., Khader, Y.S., Hakooz, N. et al. Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan. Endocrine 43, 112–119 (2013). https://doi.org/10.1007/s12020-012-9723-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9723-y